Literature DB >> 8245350

Natural history of idiopathic dilated cardiomyopathy: effect of referral bias and secular trend.

M M Redfield1, B J Gersh, K R Bailey, D J Ballard, R J Rodeheffer.   

Abstract

OBJECTIVES: The current study was designed to determine the effect of secular trend and referral bias on the natural history of idiopathic dilated cardiomyopathy.
BACKGROUND: In a previous study of 104 patients with idiopathic dilated cardiomyopathy conducted in a referral population at the Mayo Clinic between 1960 and 1973, the 1- and 5-year mortality rates were 31% and 64%, respectively. A recent study of 40 patients with idiopathic dilated cardiomyopathy conducted in a population-based cohort at the Mayo Clinic between 1975 and 1984 reported 1- and 5-year mortality rates of 5% and 20%, respectively. We hypothesized that improvements in diagnosis and therapy have occurred since the original referral cohort was described and that these improvements have altered the apparent natural history of the disease. We refer to this effect as secular trend. Alternatively, the presence of more advanced disease in the referral population (referral bias) may also contribute to the differences in survival.
METHODS: Two sequential referral populations with idiopathic dilated cardiomyopathy seen at the Mayo Clinic between 1976 and 81 (n = 85) and 1982 and 1987 (n = 137) were identified. Outcome was compared between these cohorts and the 1960-1973 referral cohort to examine the effect of secular trend. Outcomes were compared with that of the population-based cohort to examine the effect of referral bias.
RESULTS: Survival in the 1976-1981 referral cohort did not differ from that in the 1960-1973 referral cohort, suggesting little impact of secular trend during these time periods. Survival in the more recent 1982-1987 referral cohort was significantly better than that in the earlier referral cohorts, suggesting that improvements in diagnosis and treatment in the 1980s altered the natural history of idiopathic dilated cardiomyopathy. Survival in the 1982-1987 referral cohort was still worse than that of the population-based cohort, suggesting an effect of referral bias on studies of the natural history of idiopathic dilated cardiomyopathy.
CONCLUSIONS: The current study demonstrates that secular trend and referral bias affect the apparent natural history of idiopathic dilated cardiomyopathy. Survival in referral patients with this disease is significantly better than previously described.

Entities:  

Mesh:

Year:  1993        PMID: 8245350     DOI: 10.1016/0735-1097(93)90780-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

Review 1.  Secondary prevention of sudden death.

Authors:  R Cappato; K H Kuck
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

2.  Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.

Authors:  Melanie D Everitt; Lynn A Sleeper; Minmin Lu; Charles E Canter; Elfriede Pahl; James D Wilkinson; Linda J Addonizio; Jeffrey A Towbin; Joseph Rossano; Rakesh K Singh; Jacqueline Lamour; Steven A Webber; Steven D Colan; Renee Margossian; Paul F Kantor; John L Jefferies; Steven E Lipshultz
Journal:  J Am Coll Cardiol       Date:  2014-02-19       Impact factor: 24.094

3.  Black-white differences in mortality in idiopathic dilated cardiomyopathy: the Washington, DC, dilated cardiomyopathy study.

Authors:  S S Coughlin; J S Gottdiener; K L Baughman; A Wasserman; E S Marx; M C Tefft; B J Gersh
Journal:  J Natl Med Assoc       Date:  1994-08       Impact factor: 1.798

4.  Complication rates between local and referral patients undergoing vaginal hysterectomy at an academic medical center.

Authors:  Christine A Heisler; L Joseph Melton; Amy L Weaver; John B Gebhart
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

5.  ABCA5 resides in lysosomes, and ABCA5 knockout mice develop lysosomal disease-like symptoms.

Authors:  Yoshiyuki Kubo; Sayaka Sekiya; Megumi Ohigashi; Chiemi Takenaka; Kyoko Tamura; Shigeyuki Nada; Tsuyoshi Nishi; Akitsugu Yamamoto; Akihito Yamaguchi
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 6.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

7.  Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course.

Authors:  Y Yazaki; M Isobe; W Takahashi; H Kitabayashi; O Nishiyama; M Sekiguchi; T Takemura
Journal:  Heart       Date:  1999-02       Impact factor: 5.994

8.  Population-based epidemiology of intensive care: critical importance of ascertainment of residency status.

Authors:  Kevin B Laupland
Journal:  Crit Care       Date:  2004-10-15       Impact factor: 9.097

Review 9.  Oral Chinese Herbal Medicine for Treatment of Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis.

Authors:  Yu-Shuo Zhu; Yun-Lun Li; Jian-Qing Ju; Feng Du; Yan-Ping Zang; Xiao-Bing Wang; Jie Sheng
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-18       Impact factor: 2.629

Review 10.  Review of canine dilated cardiomyopathy in the wake of diet-associated concerns.

Authors:  Sydney R McCauley; Stephanie D Clark; Bradley W Quest; Renee M Streeter; Eva M Oxford
Journal:  J Anim Sci       Date:  2020-06-01       Impact factor: 3.159

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.